Allergy immunotherapy market is anticipated to grow at a CAGR of 8.2% during the forecast period. Factor such as increasing awareness of allergies in patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis. As per the Centers for Disease Control and Prevention (CDC), more than 8% of adults in the US suffer from sinusitis and hay fever. With the awareness created by these organizations; governments of different countries have sanctioned budgets for the R&D of allergy immunotherapy as an effective cure. Thus, this factor has a positive impact on the growth of the allergy immunotherapy market during the forecast period.
The factors such as the growing prevalence of gastrointestinal diseases, rising investments, and funding in the field of life science research boost the growth of the allergy immunotherapy market during the forecast period. Allergy immunotherapy is also known as hypo-sensitization. It is a type of medical treatment that allows for tackling various types of allergies. There has been significant growth in the various types of allergies across the globe. Pharmacotherapy is not enough to tackle and control the occurrence of these allergic disorders. Therefore, it is a major driving factor for the development of the allergy immunotherapy market. The use of these treatments enables building up the tolerance level against the allergic substances and enables altering the course of the disorders.
To Request a Sample of our Report on Allergy Immunotherapy Market: https://www.omrglobal.com/request-sample/allergy-immunotherapy-market
Allergy Immunotherapy Market- Segmentation
By Type
- Allergic Rhinitis
- Allergic Asthma
- Food Allergy
- Drug Allergy
- Others
By Treatment
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
A full Report of Allergy Immunotherapy Market is Available @ https://www.omrglobal.com/industry-reports/allergy-immunotherapy-market
Allergy Immunotherapy Market – Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- Aimmune Therapeutics, Inc.
- ALK-Abello A/S
- Allergopharma (A Division of Merck KGaA)
- Allergy Therapeutics PLC
- Biomay AG
- CircassiaPharmaceuticals PLC
- DBV Technologies S.A.
- Desentum Oy
- HAL Allergy Group
- Jubilant Life Sciences, Ltd.
- LetiPharma
- Merck KGaA
- Sandoz, Inc.
- Stallergenes GREER, Ltd.
- Torii Pharmaceutical Co, Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/allergy-immunotherapy-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
